Drug intelligence / Profile preview

BRP-412

Development stage
Unknown
Lead developer
Bioron Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

BRP-412 is an investigational small molecule therapeutic candidate developed by Bioron Pharma for the treatment of Major Depressive Disorder (MDD). According to company pipeline documentation, the drug is currently in Phase 2b clinical development. As a small molecule antidepressant candidate, BRP-412 is intended to address the unmet needs of patients suffering from MDD, a debilitating mental health condition characterized by persistent low mood, cognitive impairment, and loss of interest in daily activities. While specific details regarding its molecular target—such as neurotransmitter receptors or enzymatic pathways—have not been publicly disclosed in clinical registries or peer-reviewed literature, its progression to Phase 2b suggests it is being evaluated for efficacy, safety, and optimal dosing in patient populations.

Other names
BRP-412BRP412BRP 412

Beyond the preview

Go deeper on BRP-412.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRP-412.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call